Stage IVB Uterine Corpus Cancer AJCC v8
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12565 | Abexinostat | 1 | Withdrawn | 1 |
DB00062 | Albumin human | 1 | Recruiting | 1 |
DB11595 | Atezolizumab | 1 | Recruiting | 1 |
DB00112 | Bevacizumab | 1 | Recruiting | 1 |
DB08875 | Cabozantinib | 1 | Recruiting | 1 |
DB12218 | Capivasertib | 1 | Recruiting | 1 |
DB14917 | Ceralasertib | 1 | Recruiting | 1 |
DB14547 | Chloride ion | 1 | Recruiting | 1 |
DB00515 | Cisplatin | 1 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB00694 | Daunorubicin | 1 | Recruiting | 1 |
DB00997 | Doxorubicin | 1 | Recruiting | 1 |
DB00544 | Fluorouracil | 1 | Recruiting | 1 |
DB00947 | Fulvestrant | 1 | Withdrawn | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB00762 | Irinotecan | 1 | Recruiting | 1 |
DB00650 | Leucovorin | 1 | Recruiting | 1 |
DB00305 | Mitomycin | 1 | Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB00526 | Oxaliplatin | 1 | Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 2 |
DB09073 | Palbociclib | 1 | Withdrawn | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB12257 | Platinum | 1 | Recruiting | 1 |
DB00020 | Sargramostim | 1 | Recruiting | 1 |
DB11760 | Talazoparib | 1 | Recruiting | 1 |
DB14962 | Trastuzumab deruxtecan | 1 | Recruiting | 1 |
DB01590 | Everolimus | 2 | Active Not Recruiting | 1 |
DB01006 | Letrozole | 2 | Active Not Recruiting | 1 |
DB11730 | Ribociclib | 2 | Active Not Recruiting | 1 |